Videos

Dr. David Hudesman expects drug developers to continue to target biologics for the treatment of IBD. 

David Hudesman, MD: Where Drug Development is Going in IBD

Machine learning algorithms successfully predicted visual and anatomic outcomes and dosing frequency in patients with macular edema secondary to CRVO. 

Yasha Modi, MD: Machine Learning Helps Predict Visual Outcomes, Treatment Patterns

Articles

Event rates were inversely proportional to kidney function in patients with chronic coronary disease.

 Invasive Management Shows No QoL Benefit in Patients with Poorer Kidney Function 

Once a day readings over a year would detect 98.3% of the first Afib >24 hour episodes, while the probability of ≥1 false positive reading would be 98%.

Sequential Smartwatch Readings for Atrial Fibrillation Have High Detection Rates 

Dr. Modi discusses the pending approval of faricimab for nAMD, DME treatment and highlights important observations from phase 3 data. 

Yasha S. Modi, MD: Defining The Utility and Durability Of Faricimab

The first iteration of Crisis Point addresses the obesity crisis in the United States and beyond, with expert interviews and discussion.  

Crisis Point - Obesity Crisis

Episode 4 of Crisis Point asks the question you've been waiting for, "What is blueprint to resolving the obesity crisis?"

Building the Blueprint to Resolve the Obesity Crisis

Episode 3 of Crisis Point examines the regional differences in obesity, from issues with nutrition and food insecurity to the use of the phrase "food desert". 

Regional Differences in the Obesity Crisis

Episode 2 of HCPLive Crisis Point tackles the clinical aspects and potential burdens clinicians face in the pursuit of obesity care. 

Burdens of Clinical Care in the Obesity Crisis 

HCPLive Crisis Point takes an in-depth look at the obesity crisis, beginning with the process of medical diagnosis and who is impacted the most by the disease. 

NYU Langone Health

Latest News